Doximity's Double-Digit Growth Rate is Sustainable, RBC Says

MT Newswires Live01-10

Doximity's (DOCS) double-digit growth rate is sustainable through higher penetration of health care professional marketing, RBC Capital Markets said in a Thursday note, as it initiated coverage on the stock.

The firm said that Doximity is one of the "highest quality" health care technology stocks in the sector with double-digit growth and margins of over 50%.

RBC said that while pharma marketing budgets are under pressure, allocation to health care professional marketing is expected to offset this pressure.

RBC said that increased allocation by Mega brands to health care professional marketing can yield net revenue retention of 113% due to renewals and upsells.

The firm said that concerns surrounding regulatory headwinds and scrutiny from the US Food and Drug Administration into direct-to-consumer marketing are "overdone".

RBC has an outperform rating on the stock and a $59 price target.

Price: 43.81, Change: +0.06, Percent Change: +0.15

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment